Gut microbiota, a new frontier to understand traditional Chinese medicines

被引:288
作者
Feng, Wuwen [1 ]
Ao, Hui [1 ]
Peng, Cheng [1 ,2 ]
Yan, Dan [3 ]
机构
[1] Chengdu Univ Tradit Chinese Med, Sch Pharm, Chengdu, Sichuan, Peoples R China
[2] Chengdu Univ Tradit Chinese Med, Key Lab Characterist Chinese Med Resources Southw, Chengdu, Sichuan, Peoples R China
[3] Capital Med Univ, Beijing Shijitan Hosp, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
Gut microbiota; Traditional Chinese medicine; Herbal medicine; Metabolomics; CHAIN FATTY-ACIDS; HUMAN INTESTINAL BACTERIA; PERSONALIZED MEDICINE; ORAL BIOAVAILABILITY; INDIGO-NATURALIS; BARRIER FUNCTION; DRUG DISCOVERY; HUANGQIN-TANG; LIVER-DISEASE; METABOLISM;
D O I
10.1016/j.phrs.2019.02.024
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
As an important component of complementary and alternative medicines, traditional Chinese medicines (TCM) are gaining more and more attentions around the world because of the powerful therapeutic effects and less side effects. However, there are still some doubts about TCM because of the questionable TCM theories and unclear biological active compounds. In recent years, gut microbiota has emerged as an important frontier to understand the development and progress of diseases. Together with this trend, an increasing number of studies have indicated that drug molecules can interact with gut microbiota after oral administration. In this context, more and more studies pertaining to TCM have paid attention to gut microbiota and have yield rich information for understanding TCM. After oral administration, TCM can interact with gut microbiota: (1) TCM can modulate the composition of gut microbiota; (2) TCM can modulate the metabolism of gut microbiota; (3) gut microbiota can transform TCM compounds. During the interactions, two types of metabolites can be produced: gut microbiota metabolites (of food and host origin) and gut microbiota transformed TCM compounds. In this review, we summarized the interactions between TCM and gut microbiota, and the pharmacological effects and features of metabolites produced during interactions between TCM and gut microbiota. Then, focusing on gut microbiota and metabolites, we summarized the aspects in which gut microbiota has facilitated our understanding of TCM. At the end of this review, the outlooks for further research of TCM and gut microbiota were also discussed.
引用
收藏
页码:176 / 191
页数:16
相关论文
共 192 条
[1]   Biotransformation of phorbol by human intestinal bacteria [J].
Abdel-Hafez, AAM ;
Nakamura, N ;
Hattori, M .
CHEMICAL & PHARMACEUTICAL BULLETIN, 2002, 50 (02) :160-164
[2]   The role of the gut microbiota in nonalcoholic fatty liver disease [J].
Abu-Shanab, Ahmed ;
Quigley, Eamonn M. M. .
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2010, 7 (12) :691-701
[3]   Indigo Naturalis Ameliorates Oxazolone-Induced Dermatitis but Aggravates Colitis by Changing the Composition of Gut Microflora [J].
Adachi, Soichiro ;
Hoshi, Namiko ;
Inoue, Jun ;
Yasutomi, Eiichiro ;
Otsuka, Takafumi ;
Dhakhwa, Ramesh ;
Wang, Zi ;
Koo, Yuna ;
Takamatsu, Toshihiro ;
Matsumura, Yuriko ;
Yamairi, Haruka ;
Watanabe, Daisuke ;
Ooi, Makoto ;
Tanahashi, Toshihito ;
Nishiumi, Shin ;
Yoshida, Masaru ;
Azuma, Takeshi .
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2017, 173 (01) :23-33
[4]   Balicalin, the predominant flavone glucuronide of scutellariae radix, is absorbed from the rat gastrointestinal tract as the aglycone and restored to its original form [J].
Akao, T ;
Kawabata, K ;
Yanagisawa, E ;
Ishihara, K ;
Mizuhara, Y ;
Wakui, Y ;
Sakashita, Y ;
Kobashi, K .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2000, 52 (12) :1563-1568
[5]   INTESTINAL BACTERIAL HYDROLYSIS IS INDISPENSABLE TO ABSORPTION OF 18-BETA-GLYCYRRHETIC ACID AFTER ORAL-ADMINISTRATION OF GLYCYRRHIZIN IN RATS [J].
AKAO, T ;
HAYASHI, T ;
KOBASHI, K ;
KANAOKA, M ;
KATO, H ;
KOBAYASHI, M ;
TAKEDA, S ;
OYAMA, T .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1994, 46 (02) :135-137
[6]   An Integrated Metabolomic and Microbiome Analysis Identified Specific Gut Microbiota Associated with Fecal Cholesterol and Coprostanol in Clostridium difficile Infection [J].
Antharam, Vijay C. ;
McEwen, Daniel C. ;
Garrett, Timothy J. ;
Dossey, Aaron T. ;
Li, Eric C. ;
Kozlov, Andrew N. ;
Mesbah, Zhubene ;
Wang, Gary P. .
PLOS ONE, 2016, 11 (02)
[7]   Procyanidin Dimers Are Metabolized by Human Microbiota with 2-(3,4-Dihydroxyphenyl)acetic Acid and 5-(3,4-Dihydroxyphenyl)-γ-valerolactone as the Major Metabolites [J].
Appeldoorn, Maaike M. ;
Vincken, Jean-Paul ;
Aura, Anna-Marja ;
Hollman, Peter C. H. ;
Gruppen, Harry .
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2009, 57 (03) :1084-1092
[8]   Enterotypes of the human gut microbiome [J].
Arumugam, Manimozhiyan ;
Raes, Jeroen ;
Pelletier, Eric ;
Le Paslier, Denis ;
Yamada, Takuji ;
Mende, Daniel R. ;
Fernandes, Gabriel R. ;
Tap, Julien ;
Bruls, Thomas ;
Batto, Jean-Michel ;
Bertalan, Marcelo ;
Borruel, Natalia ;
Casellas, Francesc ;
Fernandez, Leyden ;
Gautier, Laurent ;
Hansen, Torben ;
Hattori, Masahira ;
Hayashi, Tetsuya ;
Kleerebezem, Michiel ;
Kurokawa, Ken ;
Leclerc, Marion ;
Levenez, Florence ;
Manichanh, Chaysavanh ;
Nielsen, H. Bjorn ;
Nielsen, Trine ;
Pons, Nicolas ;
Poulain, Julie ;
Qin, Junjie ;
Sicheritz-Ponten, Thomas ;
Tims, Sebastian ;
Torrents, David ;
Ugarte, Edgardo ;
Zoetendal, Erwin G. ;
Wang, Jun ;
Guarner, Francisco ;
Pedersen, Oluf ;
de Vos, Willem M. ;
Brunak, Soren ;
Dore, Joel ;
Weissenbach, Jean ;
Ehrlich, S. Dusko ;
Bork, Peer .
NATURE, 2011, 473 (7346) :174-180
[9]   Metabolism of 20(S)- and 20(R)-ginsenoside Rg3 by human intestinal bacteria and its relation to in vitro biological activities [J].
Bae, EA ;
Han, MJ ;
Choo, MK ;
Park, SY ;
Kim, DH .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2002, 25 (01) :58-63
[10]  
Bellaguarda E., 2015, Curr Gastroenterol Rep, V17, P15, DOI [DOI 10.1007/S11894-015-0439-Z, 10.1007/s11894-015-0439-z]